日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transcription factor switching drives subtype-specific pancreatic cancer

转录因子转换驱动亚型特异性胰腺癌

Shalini V Rao,Lisa Young,Danya Cheeseman,Sean Flynn,Niklas Krebs,Dominique-Laurent Couturier,Stephanie Mack,Rebecca Brais,Jill Temple,Amy Smith,Evangelia Papachristou,Catarina Pelicano,Chandra Sekhar Reddy Chilamakuri,Krzysztof Herka,Hideo Baba,Luay Farah,Phyllis F Cheung,Jens Siveke,Stéphane Guerrier,Luca Insolia,Michael Gill,Emily Archer Goode,Steven Kupczak,Yi Cheng,Giacomo Borsari,Duncan Jodrell,Clive D'Santos,Alasdair Russell,Barbara T Grünwald,Eva Serrao,Igor Chernukhin,Jason S Carroll

Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer

MAPK信号通路活性的差异决定了胰腺癌中成纤维细胞的亚型

Lisa Veghini # ,Davide Pasini # ,Rui Fang # ,Pietro Delfino ,Dea Filippini ,Christian Neander ,Caterina Vicentini ,Elena Fiorini ,Francesca Lupo ,Sabrina L D'Agosto ,Carmine Carbone ,Antonio Agostini ,Geny Piro ,Diego Rosa ,Michele Bevere ,Peter Markus ,Diana Behrens ,Claudio Luchini ,Rita T Lawlor ,Aldo Scarpa ,Giulia Biffi ,Phyllis F Cheung ,Jens T Siveke ,Vincenzo Corbo

Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription

拓扑异构酶1和BRD4介导的暂停释放的共同抑制可通过通读转录选择性地杀死胰腺癌细胞。

Donald P Cameron ,Jan Grosser ,Swetlana Ladigan ,Vladislav Kuzin ,Evanthia Iliopoulou ,Anika Wiegard ,Hajar Benredjem ,Kathryn Jackson ,Sven T Liffers ,Smiths Lueong ,Phyllis F Cheung ,Deepak Vangala ,Michael Pohl ,Richard Viebahn ,Christian Teschendorf ,Heiner Wolters ,Selami Usta ,Keyi Geng ,Claudia Kutter ,Marie Arsenian-Henriksson ,Jens T Siveke ,Andrea Tannapfel ,Wolff Schmiegel ,Stephan A Hahn ,Laura Baranello

Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy

成纤维细胞活化蛋白靶向微型抗体-IRDye700DX 用于光动力疗法消融癌症相关成纤维细胞

Esther M M Smeets, Daphne N Dorst, Gerben M Franssen, Merijn S van Essen, Cathelijne Frielink, Martijn W J Stommel, Marija Trajkovic-Arsic, Phyllis F Cheung, Jens T Siveke, Ian Wilson, Alessandro Mascioni, Erik H J G Aarntzen, Sanne A M van Lith

Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma

双重 BET/HDAC 抑制剂治疗胰腺导管腺癌的表征

Xin Zhang, Tim Zegar, Tim Weiser, Feda H Hamdan, Benedict-Tilman Berger, Romain Lucas, Dimitrios-IIias Balourdas, Swetlana Ladigan, Phyllis F Cheung, Sven-Thorsten Liffers, Marija Trajkovic-Arsic, Bjoern Scheffler, Andreas C Joerger, Stephan A Hahn, Steven A Johnsen, Stefan Knapp, Jens T Siveke